Home » Topics » Regulatory » Patents

Patents
RSS

Potential hypertension treatment from Pola

July 19, 1996

NEP inhibitors described by Tanabe Seiyaku

July 19, 1996

Angiotensin II antagonists described by Kotobuki Seiyaku

July 19, 1996

5-Lipoxygenase inhibitors reported by Pfizer

July 19, 1996

Muscarinic cholinergic ligands described by Novo Nordisk

July 19, 1996

Neurogen reveals D3/D4 receptor-selective compounds

July 19, 1996

5-HT1A receptor-selective agents from American Home Products

July 19, 1996

Cholesterol absorption inhibitors from Schering-Plough

July 19, 1996

Bile acid reabsorption inhibitors described by Glaxo Wellcome

July 19, 1996

Cathepsin L inhibitors described by Takeda

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...